Form 4 for BSX Boston Scientific
Accepted 2021-12-29 00:00:00 ET · period of report 2021-12-28 · accession 0001225208-21-015271 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-29 | 2021-12-28 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | S - Sale | $43.21 | -7,018 | 26.2K | -21% | -$303.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-28 | S | D | 7,018 | $43.21 | 26,243 | D | — | — | (F2) Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. |